| DIRECT COMPETITOR COMPARISON | |
| GNBT | CPEX | MNKD | NVO | Industry | | Market Cap: | 120.76M | 27.35M | 784.00M | 39.48B | 75.74M | | Employees: | 43 | 18 | 580 | 28,497 | 38 | | Qtrly Rev Growth (yoy): | 67.10% | 25.50% | N/A | 11.30% | 3.00% | | Revenue (ttm): | 1.12M | 17.67M | N/A | 10.18B | 17.49M | | Gross Margin (ttm): | 52.82% | 100.00% | N/A | 79.57% | 59.44% | | EBITDA (ttm): | -25.45M | -1.60M | -216.74M | 3.52B | -6.12M | | Oper Margins (ttm): | -2,347.43% | -12.89% | N/A | 29.92% | -3.79% | | Net Income (ttm): | -45.81M | -2.25M | -243.87M | 2.17B | N/A | | EPS (ttm): | -0.317 | -0.902 | -2.351 | 3.56 | -0.19 | | P/E (ttm): | N/A | N/A | N/A | 18.60 | 15.40 | | PEG (5 yr expected): | N/A | N/A | N/A | 1.19 | 1.31 | | P/S (ttm): | 110.39 | 1.58 | N/A | 3.82 | 3.40 |
|
| CPEX = CPEX Pharmaceuticals, Inc. | | MNKD = MannKind Corp. | | NVO = Novo Nordisk A/S | | Industry = Drug Delivery | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.08 | 0.49% | 57.77B | 12.45 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.45 | 0.15% | 13.72B | 15.88 | | Genzyme Corp. | GENZ | 51.52 | 2.26% | 13.67B | 29.37 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.98 | 0.04% | 42.28B | 18.17 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.89 | 1.41% | 9.08B | 1038.57 | | Teva Pharmaceutical Industries Limited | TEVA | 53.16 | -0.21% | 46.83B | 48.64 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.81 | 2.05% | 4.01B | 19.49 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 12.08 | 0.00% | 3.00B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.29 | -0.05% | 5.59B | 112.21 | | Pfizer Inc. | PFE | 18.59 | 1.53% | 150.01B | 15.44 | | Johnson & Johnson | JNJ | 63.30 | 0.19% | 174.65B | 13.82 | | GlaxoSmithKline plc | GSK | 42.88 | 1.42% | 108.70B | 13.53 | | Sanofi-Aventis | SNY | 39.46 | 2.15% | 103.03B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.85 | 0.99% | 126.85B | 16.72 | | RHHBY.PK | 42.29 | 2.03% | N/A | N/A | | AstraZeneca plc | AZN | 46.38 | 2.50% | 67.25B | 9.31 | | Abbott Laboratories | ABT | 54.41 | 0.31% | 84.16B | 14.74 | | Bristol-Myers Squibb Co. | BMY | 25.65 | 1.95% | 50.81B | 13.27 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | NVO | | The Complete List of Danish ADR Stocks
Fri, Nov 20 -
at Seeking Alpha | | • | NVO | | Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show
Thu, Nov 19 -
PR Newswire | | • | MNKD | | Can This Stock Go Higher?
Wed, Nov 18 -
at Motley Fool | | • | NVO | | Secure Your Future Forever With These Stocks
Tue, Nov 17 -
at Motley Fool | | • | NVO | | Music to Health-Care Investors' Ears
Mon, Nov 16 -
at Motley Fool | | • | MNKD | | Merck's Dick Clark Has Opportunities, but All Are Risky
Mon, Nov 16 -
at The Wall Street Journal Online | | • | NVO | | International Healthcare Stock Picks From Natcan Investment Management
Mon, Nov 16 -
Wall Street Transcript | | • | CPEX | | CPEX PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
Thu, Nov 12 -
EDGAR Online | | • | MNKD | | This Drug Firm Will Snap Up 50% By Mid-2010: Trader
Thu, Nov 12 -
at CNBC | | • | MNKD | | Mannkind Draws Bet on Big Upside Move
Thu, Nov 12 -
at TheStreet.com | | • | MNKD | | MANNKIND CORP Financials
Fri, Nov 6 -
EDGAR Online Financials | | • | CPEX | | CPEX's Nasulin Insulin Therapy Featured in an Oral Presentation and Four Abstracts at the Ninth Annual Diabetes Technology Meeting
Thu, Nov 5 -
Business Wire | | • | CPEX | | CPEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition
Wed, Nov 4 -
EDGAR Online | | • | CPEX | | CPEX Pharmaceuticals Reports Third-Quarter 2009 Financial Results
Wed, Nov 4 -
Business Wire | | • | MNKD | | Trading Outlook for MannKind Corp. Issued by InvestorSoup.com
Wed, Nov 4 -
GlobeNewswire | | • | MNKD | | MannKind Beats, Awaiting FDA
Tue, Nov 3 -
Zacks.com | | • | MNKD | | HEADLINE STOCKS-U.S. small/midcap stocks to watch on Nov 3
Tue, Nov 3 -
at Reuters | | • | CPEX | | Trading Outlook for Generex Biotechnologies Corp. Issued by InvestorSoup.com
Tue, Oct 27 -
GlobeNewswire | | | All Headlines for these symbols... |
|
|
|
0.29% Nasdaq 
0.011 (2.20%) 
Competitors
